PFIZER INC Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net
PFIZER INC (PFE) had Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net of $2.00 million as of 2026-06-28, per its 10-Q filed 2026-08-04.
Financial Statements › Notes › Debt
us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet · last filed 2026-08-04
- 2026-06-28: Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net $2.00M.
- 2026-03-29: Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net $3.00M.
- 2025-12-31: Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net $3.00M.
- 2025-09-28: Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net $3.00M.
| Period end | Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net |
|---|---|
| 2026-06-28 | $2.00M 10-Q · filed 2026-08-04 |
| 2026-03-29 | $3.00M 10-Q · filed 2026-05-05 |
| 2025-12-31 | $3.00M 10-Q · filed 2026-08-04 |
| 2025-09-28 | $3.00M 10-Q · filed 2025-11-04 |
| 2025-06-29 | $4.00M 10-Q · filed 2025-08-05 |
| 2025-03-30 | $1.00M 10-Q · filed 2025-05-05 |
| 2024-12-31 | $12.00M 10-K · filed 2026-02-26 |
| 2024-09-29 | $52.00M 10-Q · filed 2024-11-04 |
| 2024-06-30 | $90.00M 10-Q · filed 2024-08-05 |
| 2024-03-31 | $64.00M 10-Q · filed 2024-05-08 |
| 2023-12-31 | $121.00M 10-K · filed 2025-02-27 |
| 2022-12-31 | $1.00M 10-K · filed 2024-02-22 |
| 2021-12-31 | $0.00 10-K · filed 2022-02-24 |
| 2021-10-03 | $1.00M 10-Q · filed 2021-11-12 |
| 2021-07-04 | $2.00M 10-Q · filed 2021-08-12 |
| 2021-04-04 | $3.00M 10-Q · filed 2021-05-13 |
| 2020-12-31 | $2.00M 10-K · filed 2022-02-24 |
| 2020-09-27 | $4.00M 10-Q · filed 2020-11-05 |
| 2020-06-28 | $14.00M 10-Q · filed 2020-08-06 |
| 2020-03-29 | $38.00M 10-Q · filed 2020-05-07 |
| 2019-12-31 | $43.00M 10-K · filed 2021-02-25 |
| 2019-09-29 | $61.00M 10-Q · filed 2019-11-07 |
| 2019-06-30 | $29.00M 10-Q · filed 2019-08-08 |
| 2019-03-31 | $9.00M 10-Q · filed 2019-05-09 |
| 2018-12-31 | $11.00M 10-K · filed 2020-02-27 |
| 2018-09-30 | $7.00M 10-Q · filed 2018-11-08 |
| 2018-07-01 | $18.00M 10-Q · filed 2018-08-09 |
| 2018-04-01 | $8.00M 10-Q · filed 2018-05-10 |
| 2017-12-31 | $12.00M 10-K · filed 2019-02-28 |
| 2016-12-31 | $11.00M 10-K · filed 2018-02-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |